Jonathan Hepple
Non Executive Director at Nucleome Therapeutics · Previously invested at Oxford Science Enterprises
Investments
3
Lead Investments
2
Highlights
Focus Areas
Biotechnology
Therapeutics
Biopharma
Genetics
Medical
Firms Invested Under
Recent Investments
